Emergent BioSolutions Inc. Form 4 (Sept. 2, 2020)

Summary

An Emergent BioSolutions Inc. [EBS] Form 4 for director SULLIVAN LOUIS W reports transactions on September 2, 2020. The reporting person sold 20,525 shares of common stock, described as previously exercised options, at a weighted average price of $111.2157, leaving 42,762 shares owned directly. The form also reports the exercise of 7,893 Employee Stock Options (Right to Buy) at $20.08, expiring 05/19/2021, and the sale of those 7,893 shares at a weighted average price of $111.2256, with 15,786 options owned afterward. The explanation of responses says the option grant is fully vested, and Daniel Woubishet signed /s/ as Attorney-in-fact on September 4, 2020.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * SULLIVAN LOUIS W (Last) (First) (Middle) 400 PROFESSIONAL DR, SUITE 400 (Street) GAITHERSBURG MD 20879 (City) (State) (Zip) | SULLIVAN LOUIS W | (Last) | (First) | (Middle) | 400 PROFESSIONAL DR, SUITE 400 | GAITHERSBURG | MD | 20879 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Emergent BioSolutions Inc. [ EBS ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) | X | Director | 10% Owner | Officer (give title below) | Other (specify below)
3. Date of Earliest Transaction
 (Month/Day/Year) 09/02/2020
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock (1) | 09/02/2020 | S | 20,525 | D | $ 111.2157 (2) | 42,762 | D
Common Stock (3) | 09/02/2020 | M | 7,893 | A | $ 20.08 | 50,655 | D
Common Stock (3) | 09/02/2020 | S | 7,893 | D | $ 111.2256 (4) | 42,762 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Employee Stock Options (Right to Buy) (3) | $ 20.08 | 09/02/2020 | M | 7,893 | (5) | 05/19/2021 | Common Stock | 7,893 | $ 0 | 15,786 | D
Explanation of Responses:
1. Consists of previously exercised options granted under the company's stock incentive plan as amended and restated.
2. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices between $110.96 and $111.40.
3. Consists of an option granted under the company's stock incentive plan as amended and restated.
4. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices between $110.96 and $111.32.
5. The option grant is fully vested.
Remarks:
/s/ Daniel Woubishet, Attorney-in-fact | 09/04/2020
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_EBS_4_filed2020-09-04_0001367644-20-000145.xml

Size

18,120 bytes

SHA-256

287127010166f0e8192415d3794fa2d79bc13a5e5063c0e55ca156006fa30132

Our copy

SEC_EBS_4_filed2020-09-04_0001367644-20-000145.xml

Original

www.sec.gov